PMID: 9160574Jan 1, 1994Paper

Sertraline in social phobia

Anxiety
D J MunjackT V Eagan

Abstract

Eleven consecutive SCID-diagnosed generalized social phobias without major depression, other prominent anxiety disorders, substance abuse, alcoholism or organic mental disorder, were treated, open label, with sertraline up to 200 mg daily for 12 weeks. There were seven completers. Of these, five showed substantial improvement, after being on sertraline 100 mg daily for two weeks (following no response to sertraline 50 mg daily for four weeks). There were few side effects among the completers. The four dropouts complained of side effects and loss of interest in continuing treatment. Final average dose for completers who responded was 170 mg daily.

References

Aug 1, 1992·Journal of Clinical Psychopharmacology·B BlackM E Tancer
Feb 1, 1992·Journal of Clinical Psychopharmacology·F R SchneierM R Liebowitz
Jun 1, 1990·Journal of Clinical Psychopharmacology·H Sternbach
May 15, 2002·Journal of Clinical Psychopharmacology·Kenneth A KobakDavid J Katzelnick
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Oct 31, 2002·Human Psychopharmacology·Johan A. Den BoerBernhard R. Slaap
Aug 17, 2000·Depression and Anxiety·R M Hirschfeld
Jan 1, 1994·Anxiety·E A MartinsB Dubbert
Jul 1, 1995·Behaviour Research and Therapy·D A HopeM A Bruch
Jan 13, 1999·Pediatric Clinics of North America·B BirmaherJ Renaud
Dec 16, 1998·Journal of Affective Disorders·R B Lydiard
Jun 16, 1997·Psychiatry Research·D CaldirolaL Bellodi
Nov 1, 2000·Clinical Psychology Review·B C FruehK L Hamlin
Jul 8, 1998·Journal of Anxiety Disorders·K S Walters, H M Inderbitzen
Jun 18, 1999·Journal of Anxiety Disorders·J B CasterD Hope
May 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·E S DummitJ A Fairbanks
Oct 26, 1999·Epilepsia·K M ConnorR Weisler
Dec 16, 1998·Journal of Affective Disorders·M Lader
Apr 17, 2001·Depression and Anxiety·D L Dunner
Jul 10, 2013·Expert Opinion on Drug Metabolism & Toxicology·Roberto MandrioliMaria Augusta Raggi
Oct 6, 2001·Arquivos de neuro-psiquiatria·A E Nardi
Jun 2, 2001·Journal of Clinical Psychopharmacology·I C Fedoroff, S Taylor
May 5, 2001·Expert Opinion on Pharmacotherapy·A L McRae, K T Brady
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Jonathan C IpserDan J Stein
Mar 14, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·R G HeimbergR C Kessler
Apr 18, 2009·Depression and Anxiety·Julia D Buckner, Norman B Schmidt
Aug 20, 2015·Iranian Journal of Psychiatry and Behavioral Sciences·Mehryar Nader-Mohammadi MoghadamFahimeh Lavasni
May 17, 2001·European Psychiatry : the Journal of the Association of European Psychiatrists·I MarteinsdottirL Ekselius

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Affective Disorders
M Van AmeringenD Streiner
The Journal of Clinical Psychiatry
C Mancini, M V Ameringen
The British Journal of Psychiatry : the Journal of Mental Science
G P AmmingerF Resch
Expert Review of Neurotherapeutics
Marina Sokolenko, Stan Kutcher
© 2021 Meta ULC. All rights reserved